1. Fasinumab in the treatment of hip and knee osteoarthritic pain: efficacy and safety in a 36-week randomized, double-blind placebo-controlled clinical trial. (April 2017) Authors: Maloney, J.; Kivitz, A.; Schnitzer, T.J.; Dakin, P.; Di Martino, S.; Gao, H.; Stehman-Breen, C.; Geba, G. Journal: Osteoarthritis and cartilage Issue: Volume 25(2017)Supplement 1 Page Start: S56 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Concordance of baseline pain measures (across two reporting instruments) influences treatment effect: post hoc analysis of a phase 3 randomized controlled trial of triamcinolone acetonide extended-release in patients with knee osteoarthritis. Issue 1 (April 2020) Authors: Conaghan, P.G.; Ross, E.; Kivitz, A.; Turk, D.C.; Spitzer, A.I.; Jones, D.G.; Lanier, R.; Cinar, A.; Lufkin, J.; Kelley, S.D. Journal: Osteoarthritis and cartilage Issue: Volume 28:Issue 1(2020)supplement Page Start: S492 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. THU0126 Evaluation of the Effect of Tofacitinib on Measured Glomerular Filtration Rate in Patients with Active Rheumatoid Arthritis. (10th June 2014) Authors: Kremer, J.; Kivitz, A.; Simon-Campos, J.; Nasanov, E.; Tony, H.; Vlahos, B.; Hammond, C.; Bukowski, J.; Li, H.; Schulman, S.; Raber, S.; Zuckerman, A.; Isaacs, J. Journal: Annals of the rheumatic diseases Issue: Volume 73:Supplement 2(2014) Page Start: 222 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. SAT0180 Onset of Action of Sarilumab in Patients with Rheumatoid Arthritis in 2 Phase 3 Studies. (15th July 2016) Authors: Fleischmann, R.; Mangan, E.K.; van Adelsberg, J.; Fay, J.; van Hoogstraten, H.; Bauer, D.; Thompson, D.; Kivitz, A.; Burmester, G.R. Journal: Annals of the rheumatic diseases Issue: Volume 75(2016)Supplement 2 Page Start: 733 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. SAT0178 Clinical Responses of Sarilumab Based on Rheumatoid Factor and Anti–Cyclic Citrullinated Peptide Antibody Status in Patients with Rheumatoid Arthritis. (15th July 2016) Authors: Emery, P.; van Hoogstraten, H.; Mangan, E.K.; van Adelsberg, J.; Fan, C.; Kivitz, A.; Pinheiro, G.da R.C.; Huizinga, T. Journal: Annals of the rheumatic diseases Issue: Volume 75(2016)Supplement 2 Page Start: 732 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. AB0848 Canakinumab Pre-Filled Syringe VS Triamcinolone Acetonide in the Treatment of Acute Gouty Arthritis Attacks: Results from A Post-Hoc Analysis in Difficult-To-Treat Patients. (10th June 2014) Authors: Sunkureddi, P.; Toth, E.; Brown, J.; Kivitz, A.; Stancati, A.; Richard, D.; Lheritier, K.; Möricke, R. Journal: Annals of the rheumatic diseases Issue: Volume 73:Supplement 2(2014) Page Start: 1083 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. SAT0389 Apremilast, an Oral Phosphodiesterase 4 Inhibitor, is Associated with Long-Term (52-Week) Improvements in Enthesitis and Dactylitis in Patients with Psoriatic Arthritis: Results from the Palace 4 Phase 3, Randomized, Controlled Trial. (10th June 2014) Authors: Edwards, C.; Wells, A.; Adebajo, A.; Kivitz, A.; Bird, P.; Shah, K.; Hu, C.; Stevens, R.M.; Aelion, J. Journal: Annals of the rheumatic diseases Issue: Volume 73:Supplement 2(2014) Page Start: 735 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. SAT0006 No Differences in Patient-Reported Outcomes by Methotrexate Dose Among Early Rheumatoid Arthritis Patients Treated Concomitantly with Adalimumab: Results from the Concerto Trial. (23rd January 2014) Authors: Fleischmann, R. M.; Kivitz, A.; van Vollenhoven, R. F.; Shaw, J. W.; Florentinus, S.; Karunaratne, M.; Kupper, H.; Dougados, M.; Burmester, G.-R. Journal: Annals of the rheumatic diseases Issue: Volume 72:Supplement 3(2013) Page Start: A580 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. THU0374 NONSTEROIDAL ANTI-INFLAMMATORY DRUG-SPARING EFFECT OF SECUKINUMAB IN PATIENTS WITH ANKYLOSING SPONDYLITIS: 4-YEAR RESULTS FROM THE MEASURE 2, 3 AND 4 PHASE 3 TRIALS. (2nd June 2020) Authors: Dougados, M.; Kiltz, U.; Kivitz, A.; Pavelka, K.; Rohrer, S.; Mccreddin, S.; Quebe-Fehling, E.; Porter, B.; Talloczy, Z. Journal: Annals of the rheumatic diseases Issue: Volume 79(2020)Supplement 1 Page Start: 419 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. SAT0120 UNITED STATES RHEUMATOLOGY PRACTICE-BASED REAL-WORLD EVIDENCE OF INFUSION REACTIONS IN RHEUMATOID ARTHRITIS PATIENTS TREATED WITH INTRAVENOUS GOLIMUMAB OR INFLIXIMAB: IMPACT OF PRIOR BIOLOGIC EXPOSURE AND METHOTREXATE UTILIZATION. (2nd June 2020) Authors: Schwartzman, S.; Broadwell, A.; Kivitz, A.; Black, S.; Xu, S.; Langholff, W.; Kafka, S. Journal: Annals of the rheumatic diseases Issue: Volume 79(2020)Supplement 1 Page Start: 994 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗